The microbiome of the female reproductive tract defies the convention that high biodiversity
is a hallmark of an optimal ecosystem. Although not universally true, a homogeneous …

Background Maternal rectovaginal colonization with group B Streptococcus (GBS) is the
most common pathway for GBS disease in mother, fetus, and newborn. This article, the …

Background Natural history studies have correlated serotype-specific anti–capsular
polysaccharide (CPS) IgG in newborns with a reduced risk of group B streptococcal disease …

Summary Background Group B streptococcus (GBS) colonisation during pregnancy can
lead to invasive GBS disease (iGBS) in infants, including meningitis or sepsis, with a high …

Background We aimed to provide the first comprehensive estimates of the burden of group B
Streptococcus (GBS), including invasive disease in pregnant and postpartum women, fetal …

Abstract Background Group B Streptococcus (GBS) remains a leading cause of neonatal
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …

Invasive disease due to group B Streptococcus infection (Streptococcus agalactiae) results
in a wide spectrum of clinical disease. In North America, serotypes Ia, Ib, II, III, and V are …

The pathway to a thriving newborn begins before conception and continues in utero with a
healthy placenta and the right balance of nutrients and growth factors that are timed and …

Background Intrapartum antibiotic chemoprophylaxis (IAP) prevents most early-onset group
B streptococcal (GBS) disease. However, there is no description of how IAP is used around …

Background Survivors of infant group B streptococcal (GBS) disease are at risk of
neurodevelopmental impairment (NDI), a burden not previously systematically quantified …